Maggie Langhamer, M.P.H., joined Statistics Collaborative, Inc. (SCI) in 2017. She is a member of the International Biometric Society – Eastern North American Region.
At SCI, Ms. Langhamer has worked with clinical trials evaluating treatments in several disease areas including glioblastoma, urothelial cancer, renal cell carcinoma, acute lymphoblastic leukemia, Alzheimer’s disease, Alport syndrome, systemic lupus erythematosus, cardiovascular disease, and weight management. As a biostatistician on these studies, she performs statistical analyses, programs datasets, generates graphs, tables, and listings, and validates program code.
In addition to her work reporting to Data Monitoring Committees, Ms. Langhamer contributes to writing statistical analysis plans and prepares and audits CDISC-compliant ADaM datasets and documentation for FDA submission.
Prior to joining SCI, Ms. Langhamer was a Graduate Research Assistant with the Global Immunization Division at the Centers for Disease Control and Prevention performing analyses on data related to routine immunization service utilization in Africa. She completed her master’s practicum at the National Cancer Institute where she was involved in research on infectious agents and cancer.
She received her B.S. magna cum laude in Biology with a double major in French and Francophone studies from Villanova University (2015) and her M.P.H. in Epidemiology from the Rollins School of Public Health at Emory University (2017). Her culminating experience research project for her M.P.H. was titled “Association between biliary tract cancers and family history of cancers in the Biliary Tract Cancers Pooling Project (BiTCaPP).”
To contact SCI about a potential project, please call us at 202.247.9700 or click below.
Statistics Collaborative is experencing a business interruption due to circumstances beyond our control. Please call our main company phone number for details and updates.